Fidelity Investments
ELTX icon

Fidelity Investments’s Elicio Therapeutics ELTX Stock Holding History

Fidelity Investments’s Portfolio ELTX Stock Details ELTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-185
Closed -$1.14K – 5372
2025
Q1 		$1.14K Buy
+185
New +$1.43K ﹤0.01% 4946
2022
Q3 		– Sell
-69
Closed -$1K – 4986
2022
Q2 		$1K Sell
69
-29
-30% -$463 ﹤0.01% 4698
2022
Q1 		$2K Buy
98
+38
+63% +$858 ﹤0.01% 4645
2021
Q4 		$2K Sell
60
-31,190
-100% -$1.58M ﹤0.01% 3998
2021
Q3 		$3.05M Hold
31,250
– – ﹤0.01% 2475
2021
Q2 		$4.07M Hold
31,250
– – ﹤0.01% 2395
2021
Q1 		$5.65M Buy
+31,250
New +$6.03M ﹤0.01% 2225

Other funds holding ELTX

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
MHC
Meyer Handelman Company Rye Brook, New York $3.53B AUM 30.49% 1-Year Est. Return

Fidelity Investments's ELTX Position: Q2 2025 in Review

Fidelity Investments sold out of Elicio Therapeutics (ELTX) in Q2 2025, closing a stake of 185 shares — an estimated $1.14K sold.

Fidelity Investments first reported a position in ELTX in Q1 2021 and held it in 7 quarters. The position peaked at $5.65M in Q1 2021. 21 funds tracked by Wall St. Rank hold ELTX as of Q2 2025.

  • Fidelity Investments reported no remaining Elicio Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Fidelity Investments sold 185 Elicio Therapeutics shares in Q2 2025, an estimated $1.14K.
  • Fidelity Investments first reported a position in Elicio Therapeutics in Q1 2021 and held it in 7 quarters.
  • Fidelity Investments's Elicio Therapeutics position peaked at $5.65M in Q1 2021.
  • 21 funds tracked by Wall St. Rank held Elicio Therapeutics as of Q2 2025.

Based on Fidelity Investments's 13F filing for Q2 2025, filed 14 Aug 2025.